Pomerantz LLP Advises Investors of Class Action Filing Involving Corcept Therapeutics Incorporated – CORT
NEW YORK CITY, NY / ACCESS Newswire / February 27, 2026 / Pomerantz LLP announces that a class action lawsuit has been filed against Corcept Therapeutics Incorporated ("Corcept" or the "Company") (NASDAQ:CORT).â?¯â?¯ Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are […]